Trials / Completed
CompletedNCT02386163
Large-scale ex Vivo Expansion and Characterization of Two Kinds of MSC From Knee for Clinical Application
Large-scale ex Vivo Expansion and Characterization of Synovial Membrane MSC (SM-MSC) and Infrapatellar Fat Pad MSC (IF-MSC) for Clinical Application
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 6 (actual)
- Sponsor
- EMO Biomedicine Corporation · Industry
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- Not accepted
Summary
According to many researches, mesenchymal stem cells (MSC) isolated from synovial membrane and infrapatellar fat pad have higher ex vivo proliferation capacity, multipotency and ability to undergo chondrogenesis. Based on this concept, the investigators plan to get two removed tissues (synovial membrane and infrapatellar fat pad) from patients who have an operation of TKR (Total Knee Replacement). The investigators are going to isolate and expand MSC from these two tissues respectively, and then compare their characterization and potential for clinical application. In the other hand, the investigators plan to build techniques and procedures which comply with "Good Tissue Practices (GTP)".
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | MSC from synovial membrane and infrapatellar Fat Pad |
Timeline
- Start date
- 2014-05-01
- Primary completion
- 2015-08-01
- Completion
- 2015-08-01
- First posted
- 2015-03-11
- Last updated
- 2015-09-10
Locations
1 site across 1 country: Taiwan
Source: ClinicalTrials.gov record NCT02386163. Inclusion in this directory is not an endorsement.